Is cancer treatment headed toward an HIV-like business model? From John LaMattina’s blog: http://www.forbes.com/sites/johnlamattina/2013/11/13/biopharma-alliances-will-be-needed-for-cancer-drugs-in-the-cost-conscious-future/